Combined Behavioral and Analgesic Trial for Fibromyalgia

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Fibromyalgia
Interventions
DRUG

Tramadol

"50 mg tablets titrated up to 2 tablets four times per day for a maximum dose of 400mg per day.~Minimum accepted dose of 200mg per day"

DRUG

Placebo

Pharmacological inactive tablet, 50mg tablets titrated to 2 tabs per day up to 400mg

BEHAVIORAL

Cognitive Behavior Therapy for FM

Subjects will be seen for 8 weekly 50 minute sessions of Cognitive Behavior Therapy that has been specifically tailored for Fibromyalgia patients.

BEHAVIORAL

Health Education

Subjects will receive 8 weekly 50 minute sessions of Health Education on Fibromyalgia

Trial Locations (2)

98195

University of Washington, Seattle

Unknown

University of Rochester, Rochester

All Listed Sponsors
lead

University of Washington

OTHER

NCT01598753 - Combined Behavioral and Analgesic Trial for Fibromyalgia | Biotech Hunter | Biotech Hunter